Zyla Life Sciences (ZCOR) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 58 transactions totaling $750.0K, demonstrating a bearish sentiment with -$750.0K in net insider flow. The most recent transaction on May 20, 2020 involved a transaction of 107,951 shares valued at $0.
No significant insider buying has been recorded for ZCOR in the recent period.
No significant insider selling has been recorded for ZCOR in the recent period.
Based on recent SEC filings, insider sentiment for ZCOR is bearish with an Insider Alignment Score of 0/100 and a net flow of -$750.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Zyla Life Sciences (ZCOR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading ZCOR stock, having executed 58 transactions in the past 90 days. The most active insider is Ridge Gp Llc Riva (Executive), who has made 2 transactions totaling $750.0K.
Get notified when executives and directors at ZCOR file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 20, 2020 | C. Timmins Megan | Executive | Disposition | 107,951 | $N/A | $0 | |
| May 20, 2020 | N. Smith Todd | Executive | Disposition | 365,500 | $N/A | $0 | |
| May 20, 2020 | Pauls Matthew | Executive | Disposition | 26,953 | $N/A | $0 | |
| May 20, 2020 | M. Phillips Gary | Executive | Disposition | 33,620 | $N/A | $0 | |
| May 20, 2020 | Heslin Smiley Andrea | Executive | Disposition | 26,953 | $N/A | $0 | |
| May 20, 2020 | P. Walbert Timothy | Executive | Disposition | 26,953 | $N/A | $0 | |
| May 20, 2020 | Strobeck Mark | Executive | Disposition | 180,864 | $N/A | $0 | |
| May 20, 2020 | Mcinnis Joe | Executive | Disposition | 26,953 | $N/A | $0 | |
| May 20, 2020 | III (cayman) Unlev Aiv I. L.p. Crg Partners | Executive | Disposition | 4,586,874 | $N/A | $0 | |
| Apr 23, 2020 | Mcinnis Joe | Executive | Payment | 952 | $1.75 | $1.7K | |
| Apr 23, 2020 | Mcinnis Joe | Executive | Option Exercise | 6,667 | $1.75 | $11.7K | |
| Apr 23, 2020 | Pauls Matthew | Executive | Payment | 952 | $1.75 | $1.7K | |
| Apr 23, 2020 | Pauls Matthew | Executive | Option Exercise | 6,667 | $1.75 | $11.7K | |
| Apr 23, 2020 | Heslin Smiley Andrea | Executive | Payment | 952 | $1.75 | $1.7K | |
| Apr 23, 2020 | Heslin Smiley Andrea | Executive | Option Exercise | 6,667 | $1.75 | $11.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 18 | $751.2K | 43.1% |
Sale(S) | 2 | $750.0K | 43.0% |
Payment(F) | 12 | $243.6K | 14.0% |
Disposition(D) | 9 | $0 | 0.0% |
Award(A) | 15 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insider selling pressure at Zyla Life Sciences has increased, with 13 insiders executing 58 transactions across all time. Total sales of $750.0K significantly outpace purchases of $0, resulting in a net outflow of $750.0K. This selling activity appears largely discretionary, which may warrant closer attention from investors.